Two new videos about Bioasis were released this week from https://equity.guru/ :

1.     Jody Vance interview with Deborah Rathjen (Executive Chair, Bioasis)

https://www.youtube.com/watch?v=w7Lmh3hc9Pw

2.     2 min 56 sec Company Overview

https://www.youtube.com/watch?v=w1XXYEr9a4s

In addition to the three recent articles from them:

https://equity.guru/2021/07/07/bioasis-technologies-bti-v-announces-positive-results-from-xb3-il-1ra-study/

https://equity.guru/2021/07/06/bioasis-technologies-bti-v-stock-is-on-the-move-following-scientific-validation-of-xb3-platform/

https://equity.guru/2021/07/02/bioasis-bti-v-begins-research-collaboration-oxyrane-uk-appoints-new-cfo/

and their original introduction article https://equity.guru/2021/06/03/bioasis-technologies-bti-v-biopharma-dark-horse-in-the-making/

And this article https://themarketherald.ca/bioasis-announces-positive-results-from-an-efficacy-study-of-xb3tm-il-1ra-in-a-model-of-multiple-sclerosis-2021-07-07/ , although not giving additional scientific data, does an excellent job of summarizing the il-1ra study press release in an easy-to-understand way for non-biotech people.